Ibiden Co. Ltd. reported a significant jump in profitability for the nine months ending December 31, with net profit rising to ¥31.00 billion as revenue growth outpaced the previous year. The Japanese electronics giant benefited from improved margins and resilient demand, according to the company's latest financial disclosure.
Marudai Food Co. Ltd. reported a decline in net profit for the nine months ended Dec. 31, even as the Japanese food processor saw gains in revenue and operating income. According to the company's latest financial results, net profit fell to ¥5.07 billion, down from ¥5.75 billion in the same period last year.
Malayan Banking is projected to report a 4.4% rise in fourth-quarter net profit on Thursday, buoyed by stabilizing funding costs and a recovery in regional capital flows. Analysts polled by Visible Alpha anticipate a quarterly profit of 2.64 billion ringgit ($678.5 million), marking a steady conclusion to a year defined by resilient domestic demand and a strengthening ringgit.
Japanese defense and heavy machinery shares tumbled on Tuesday after Beijing placed 40 Japanese entities on export control and monitoring lists. The move by China’s commerce ministry, which targets dual-use items with potential military applications, marks a sharp escalation in the ongoing diplomatic friction between the two economic powerhouses.
Tokyo-listed adish Co. Ltd. reported a significant recovery for the fiscal year ended December 31, nearly erasing its net loss as operating margins moved into positive territory. The company narrowed its annual deficit to just ¥1.00 million, a sharp contrast to the ¥115.00 million loss posted in the previous year.
Pfizer has struck a licensing agreement with Hangzhou Sciwind Biosciences to commercialize the metabolic drug ecnoglutide in China, a deal valued at up to $495 million. The partnership grants the U.S. pharmaceutical giant exclusive rights to a therapy already approved for diabetes and currently under regulatory review for weight management in the world’s second-largest economy.
Asian software equities retreated on Tuesday, tracking a sharp overnight selloff on Wall Street fueled by renewed skepticism over the long-term economic impact of artificial intelligence. The decline, triggered by a viral research report warning of disruption in white-collar sectors, wiped significant value off major tech players from Hong Kong to Sydney.
Major Chinese film and entertainment shares cratered Tuesday after a disappointing Lunar New Year box office performance marked the industry’s weakest holiday showing since 2018. Despite an extended nine-day break, ticket sales failed to ignite consumer interest, significantly trailing the previous year’s revenue.
United Overseas Bank shares faced their steepest one-day decline in nearly a year on Tuesday after the Singaporean lender reported a 7% drop in fourth-quarter profit and a dividend payout that failed to meet analyst projections.
United Overseas Bank (UOB) reported a 7% decline in fourth-quarter net profit to S$1.41 billion (US$1.11 billion), pressured by cooling interest income and a downward revision to its fee-growth guidance.
Consumer-facing companies saw a sharp decline in share prices as uncertainty regarding trade tariffs weighed on investor sentiment, overshadowing positive performance from individual food and retail giants. While broader market jitters persisted, Domino’s Pizza and Canadian grocer Loblaw signaled a resilient, albeit value-conscious, consumer environment.
NWPX Infrastructure has finalized the acquisition of Colorado-based concrete manufacturer Boughton’s Precast, marking its third strategic expansion in six years. The deal, which closed Monday, aims to bolster the company’s water transmission capabilities and is expected to provide an immediate boost to earnings.
Shares of major financial institutions and alternative asset managers retreated Friday as concerns mounted over the stability of the private credit market and the sustainability of high-interest deal-making. The sell-off, led by industry heavyweights Blue Owl and Blackstone, comes amid reports of funding hurdles for massive infrastructure projects and a broader tightening of deal economics driven by the Federal Reserve's restrictive monetary policy.
Teradata has reached a $480 million settlement with SAP, concluding a high-stakes legal battle that began in 2018 over allegations of trade secret theft and anticompetitive behavior. The agreement ends years of litigation between the two enterprise software rivals and provides a significant capital injection for Teradata.
Technology shares retreated as investors weighed the disruptive potential of generative artificial intelligence, with IBM leading the decline following a breakthrough announcement from AI startup Anthropic. The market reaction underscores growing anxiety over how legacy tech giants will navigate a landscape where automated tools can now handle complex coding tasks once central to their business models.
The communications services sector dipped on Thursday as investors weighed a narrowing loss at AMC Entertainment against escalating political and regulatory hurdles for Netflix.
Thor Industries is reorganizing its North American recreational vehicle business, consolidating the majority of its brands into two distinct operating groups. The manufacturer announced the move on Monday, signaling a shift toward centralized management as it navigates rapid dealer consolidation and evolving consumer demand in a post-pandemic market.
Power producers gained ground on Monday as investors pivoted toward defensive sectors, reacting to a combination of severe winter weather and a major Supreme Court ruling on trade tariffs.
Coveo, the AI-powered search and personalization platform, has officially named Karine Hamel as its permanent Chief Financial Officer, concluding a leadership transition that began late last year.
Keurig Dr Pepper has expanded its funding deal with private equity giants to $4.5 billion, paving the way for a clean separation of its beverage and coffee segments into two independent public entities. The additional capital, provided by KKR, Apollo Global Management, and T. Rowe Price, cancels previous plans for a partial initial public offering of the beverage business.
Calian Group has named Will Majic as its acting chief financial officer, filling the vacancy left by Patrick Houston’s recent elevation to the top executive post. The appointment, effective immediately, places a long-time internal veteran at the helm of the company's financial operations as it continues to execute its long-term growth strategy.
Vir Biotechnology and Astellas Pharma have entered a licensing agreement to co-develop VIR-5500, an experimental prostate cancer treatment currently in early-stage trials. The deal provides Vir with $335 million in upfront and near-term capital, signaling a major push into the competitive field of T-cell engager therapies.
Tectonic Therapeutic has appointed François Nader as chair and independent director of its board, effective April 1, as the clinical-stage biotech firm prepares for its next phase of growth.
AeroVironment announced Monday that Chief Financial Officer Kevin McDonnell will retire on July 31, concluding a six-year tenure at the defense technology firm. The company has initiated a search for a successor, with McDonnell committed to overseeing a smooth transition of the finance department.
Westlake Corp. announced Monday that longtime Chief Financial Officer Steven Bender will retire after nearly 20 years at the petrochemicals manufacturer. Bender, who has served as finance chief since 2007, will remain in his position until a successor is appointed to ensure a stable leadership transition.
The right-wing One Nation party has overtaken major political forces in New South Wales, securing 30% support in the latest Roy Morgan poll just one year ahead of the state election. With the governing Labor Party trailing at 25% and the Liberal-National coalition at 19%, the results signal a profound shift in Australia's most populous state following a period of heightened national tension.
Vir Biotechnology shares skyrocketed on Monday following a $335 million licensing agreement, while Diamondback Energy and Whirlpool faced after-hours declines amid falling oil prices and debt restructuring efforts.
MacroGenics has paused enrollment in its Phase 2 study of lorigerlimab after the U.S. Food and Drug Administration (FDA) placed a clinical hold on the trial due to severe safety concerns. The Rockville, Maryland-based biopharmaceutical company halted the study, which targets gynecological cancers, after reporting serious adverse events in four participants.
Better Home & Finance Holding Company has entered a strategic partnership with Framework Ventures to integrate its mortgage lending operations into the Sky decentralized finance ecosystem. The deal aims to deploy $500 million in credit, marking a significant bridge between traditional home equity markets and blockchain-based capital.
Haemonetics has received FDA 510(k) clearance for its NexSys PCS system featuring Persona PLUS technology, a software-driven upgrade designed to maximize donation volumes and improve efficiency for plasma collectors.
